Long term azathioprine fails to prevent onset of multiple sclerosis: Report of two cases

Multiple Sclerosis

Volumn 6, Issue 5, 2000, Pages 362-363

  Constantinescu, C S ^a   Whiteley, A ^a   Blumhardt, L D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Azathioprine; Crohns disease; Immunosuppressive treatment; Inflammatory bowel disease; Multiple sclerosis

Indexed keywords

AZATHIOPRINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MALE; MULTIPLE SCLEROSIS;

EID: 0033759179     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245850000600512     Document Type: Article

References (9)

1. Therapy
2. Overview of azathioprine treatment in multiple sclerosis
3. Discrepancies between meta-analyses and subsequent large randomized, controlled trials
4. New treatments and azathioprine in multiple sclerosis
5. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
6. Concurrence of multiple sclerosis and inflammatory bowel disease
7. Organ specific autoimmune and inflammatory disease of the central nervous system
8. Development of multiple sclerosis in patient on long-term sulfasalazine
9. The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis